Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26862095 |
CA |
32 | 1 |
Syncope, Fatigue, Dyspnoea, Asthenia, Influenza, Inappropriate schedule of product administration, |
||||
| 302 | 26862271 |
US |
45 | 2 |
Nasopharyngitis, Flushing, Peripheral coldness, Stress, Paraesthesia, Multiple sclerosis, Nausea, Fatigue, Pruritus, Diarrhoea, Gastrointestinal sounds abnormal, Hot flush, Abdominal discomfort, Alopecia, Headache, Influenza, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 303 | 26852379 |
US |
66 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 304 | 26852683 |
SA |
2 | |
Pulmonary oedema, Pyrexia, Fatigue, Arthralgia, Pain in extremity, Back pain, Blood cholesterol increased, Memory impairment, Diabetes mellitus, Hallucination, Bone pain, Dizziness postural, Balance disorder, Influenza, Gait inability, Malaise, Pain, Nervous system disorder, Sleep disorder, Ear pain, Dizziness, Urinary tract infection, Blood creatinine increased, Glycosylated haemoglobin increased, Blood glucose increased, Blood triglycerides increased, Otitis media, Intervertebral disc disorder, Blood sodium decreased, Incorrect product administration duration, Inappropriate schedule of product administration, |
||||
INCLISIRAN, |
||||
| 305 | 26852915 |
CA |
33 | |
Oropharyngeal pain, Flushing, Pruritus, Throat irritation, Dizziness, Fatigue, Headache, Influenza, Off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, |
||||
| 306 | 26853013 |
US |
7 | 1 |
Influenza, Influenza, Nausea, Vomiting, Off label use, Overdose, |
||||
INFLIXIMAB, |
||||
| 307 | 26853142 |
US |
45 | 2 |
Influenza, Hepatic enzyme increased, Dyspnoea, |
||||
GUSELKUMAB, |
||||
| 308 | 26853358 |
MY |
1 | |
Dyspnoea, Influenza, |
||||
| 309 | 26853530 |
US |
60 | 2 |
Influenza, Pneumonia, Off label use, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 310 | 26853669 |
US |
80 | 1 |
Urinary tract infection, Weight loss poor, Influenza, Incorrect route of product administration, Dehydration, Ill-defined disorder, |
||||
| 311 | 26854035 |
CA |
70 | 1 |
Blood pressure increased, Disease recurrence, Influenza, Malaise, Nasopharyngitis, Psoriasis, Therapeutic product effect decreased, Inappropriate schedule of product administration, |
||||
AMLODIPINE, BRODALUMAB, BRODALUMAB, ALLOPURINOL, |
||||
| 312 | 26854221 |
MX |
59 | 2 |
Hypertension, Urinary tract infection, Pancreatitis, Helicobacter gastritis, Renal failure, Diabetes mellitus, Influenza, Septic shock, Mental disorder, Hyperhidrosis, Secretion discharge, Product use issue, Cough, Chest discomfort, Duodenitis, Drug ineffective, Blood pressure increased, |
||||
FLUTICASONE PROPIONATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, |
||||
| 313 | 26854893 |
US |
16 | 1 |
Influenza, |
||||
DUPILUMAB, |
||||
| 314 | 26855201 |
EU |
66 | |
Influenza, Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 315 | 26855272 |
US |
69 | 2 |
Weight decreased, Influenza, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 316 | 26855397 |
2 | ||
Hospitalisation, Diverticulitis, Hot flush, Illness, Weight increased, Influenza, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 317 | 26855563 |
CA |
2 | |
Muscular weakness, Influenza, Diarrhoea, Vomiting, Pyrexia, Fatigue, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, SITAGLIPTIN, ZOLPIDEM TARTRATE, DAPSONE GEL, 5%, DAPSONE, DASPONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RISEDRONATE SODIUM, CITALOPRAM, GLYBURIDE, SITAGLIPTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, PREDNISONE, DAPAGLIFLOZIN, |
||||
| 318 | 26856197 |
CA |
61 | 2 |
Pyrexia, Sneezing, Aphasia, Cystitis, Sinus congestion, Personality disorder, Dysarthria, Dysphagia, Pneumonia, Sensory loss, Adjustment disorder, Chest discomfort, Influenza, Motor dysfunction, Carotid artery thrombosis, Confusional state, Gangrene, Headache, Hemiplegia, Muscular weakness, Nasopharyngitis, Pain, Arthritis, Cerebrovascular accident, Influenza like illness, Malaise, Muscle spasticity, Psoriasis, Skin haemorrhage, Anxiety, Arterial occlusive disease, Cataract, Fall, Fatigue, Neurologic neglect syndrome, Respiratory tract congestion, Rhinorrhoea, Sinus disorder, Sinusitis, Coordination abnormal, Eating disorder, Hemiparesis, Skin exfoliation, Vomiting, Asthenia, Blood pressure increased, Cough, Rheumatoid arthritis, Affect lability, Angina pectoris, Nausea, Palpitations, Gastrointestinal disorder, Product use issue, |
||||
ZOLPIDEM TARTRATE, LISINOPRIL, PROCHLORPERAZINE MALEATE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PREDNISONE, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SITAGLIPTIN, BISOPROLOL FUMARATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, CALCIUM CARBONATE, ANTACID, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, IRBESARTAN, ATORVASTATIN CALCIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, ESOMEPRAZOLE MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, AMLODIPINE BESYLATE, IRBESARTAN, LEVOTHYROXINE SODIUM, CALCIUM CARBONATE, CANDESARTAN CILEXETIL, INSULIN LISPRO, METHYLPREDNISOLONE ACETATE, COAL TAR, LANOLIN, METHYLPREDNISOLONE ACETATE, ACITRETIN, INSULIN GLARGINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYANOCOBALAMIN, TELMISARTAN, PANTOPRAZOLE, EZETIMIBE, PREGABALIN, DULOXETINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHYLPREDNISOLONE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, IRBESARTAN, USTEKINUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ROSUVASTATIN, |
||||
| 319 | 26856359 |
CO |
50 | 2 |
Osteoarthritis, Fall, Viral infection, Abdominal pain upper, Headache, Influenza, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 320 | 26856733 |
CA |
78 | 2 |
Lower respiratory tract infection, Dry eye, Dyspnoea, Influenza, Insomnia, Sputum discoloured, Cough, Productive cough, Malaise, Tongue disorder, Dysphagia, Respiratory symptom, Peripheral swelling, Ocular discomfort, Sinusitis, Chronic obstructive pulmonary disease, Paranasal sinus discomfort, Viral infection, Diarrhoea, |
||||
DUPILUMAB, IRBESARTAN, DIGOXIN, APIXABAN, BISOPROLOL FUMARATE, FUROSEMIDE, CALCIUM, ERGOCALCIFEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 321 | 26856869 |
US |
1 | |
Influenza, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 322 | 26847018 |
US |
1 | |
Influenza, Upper respiratory tract infection, Product dose omission issue, |
||||
PEGUNIGALSIDASE ALFA, PEGUNIGALSIDASE ALFA, |
||||
| 323 | 26847052 |
CN |
67 | 1 |
Liver injury, Influenza, |
||||
CISPLATIN, CISPLATIN, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, ETOPOSIDE, |
||||
| 324 | 26847111 |
EU |
46 | |
Pneumocystis jirovecii infection, Retroperitoneal cancer, Condition aggravated, Campylobacter bacteraemia, Immunodeficiency, COVID-19, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 325 | 26847665 |
CO |
70 | 2 |
Cardiac operation, Skin cancer, Cataract, Retinal injury, Influenza, Keloid scar, Skin disorder, Renal disorder, Cystitis, Rhinitis, Tinnitus, Gastrointestinal disorder, Hypertension, Therapy change, Blood cholesterol increased, Amnesia, Skin lesion, |
||||
EVOLOCUMAB, |
||||
| 326 | 26848137 |
US |
48 | 2 |
Influenza, Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, |
||||
| 327 | 26848235 |
US |
2 | |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 328 | 26848854 |
CA |
3 | 1 |
Epstein-Barr virus infection reactivation, Immunosuppression, Post transplant lymphoproliferative disorder, Warm autoimmune haemolytic anaemia, Influenza, Autoimmune haemolytic anaemia, Hypermetabolism, Drug effective for unapproved indication, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOSPORINE, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, TISAGENLECLEUCEL, |
||||
| 329 | 26848899 |
US |
2 | |
Myocardial infarction, Cardiac failure congestive, Influenza, Memory impairment, Dyspnoea, Blood pressure increased, Weight decreased, |
||||
| 330 | 26849241 |
CO |
40 | 2 |
Influenza, Paraesthesia, Gait disturbance, Pain in extremity, Burning sensation, Pain in jaw, Hyperaesthesia teeth, Blood triglycerides increased, |
||||
SATRALIZUMAB, ERGOCALCIFEROL, |
||||
| 331 | 26850167 |
79 | 2 | |
Cardiac disorder, Cerebrovascular accident, Pulmonary sarcoidosis, Condition aggravated, Chills, Influenza, Weight increased, Blood pressure increased, Pyrexia, Peripheral swelling, |
||||
REPOSITORY CORTICOTROPIN, PREDNISONE, |
||||
| 332 | 26850223 |
CO |
52 | 2 |
Influenza, Fatigue, Oropharyngeal pain, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 333 | 26850267 |
US |
64 | 2 |
Arachnoid cyst, Orthostatic tremor, Influenza, Inappropriate schedule of product administration, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 334 | 26850269 |
CA |
83 | 1 |
Lung neoplasm malignant, Haematological malignancy, Idiopathic pulmonary fibrosis, Haematuria, COVID-19, Depression, Productive cough, Chest pain, Influenza, Dyspepsia, Chromaturia, Abdominal pain, Dysuria, Diarrhoea, Nausea, Fatigue, Decreased appetite, Abdominal discomfort, Abdominal tenderness, Chest discomfort, Cough, Dyspnoea exertional, Oropharyngeal discomfort, Pain, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 335 | 26850313 |
US |
61 | 2 |
Intentional product misuse, Pain in extremity, Musculoskeletal stiffness, Glaucoma, Therapeutic response unexpected, Abdominal distension, Constipation, Osteoporosis, Nasopharyngitis, Influenza, Hypersensitivity, Vertigo, Pain, Muscle spasms, Muscle strain, |
||||
TOFACITINIB, TOFACITINIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, MELOXICAM, |
||||
| 336 | 26850813 |
US |
||
Immunodeficiency, Systemic lupus erythematosus, Infection, Nasopharyngitis, Influenza, Inappropriate schedule of product administration, |
||||
BELIMUMAB, BELIMUMAB, PREDNISONE, |
||||
| 337 | 26856338 |
61 | 2 | |
Therapy interrupted, Influenza, Hand deformity, |
||||
ETANERCEPT, |
||||
| 338 | 26846220 |
CA |
51 | 2 |
Extranodal marginal zone B-cell lymphoma (MALT type) stage IV, Injection site induration, Influenza, Pyrexia, Stress, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, PIMECROLIMUS, |
||||
| 339 | 26846307 |
US |
2 | |
Influenza, Prescribed underdose, |
||||
NATALIZUMAB, |
||||
| 340 | 26846688 |
EU |
47 | 1 |
COVID-19, Gastrointestinal infection, Viral infection, Respiratory tract infection, Influenza, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 341 | 26839603 |
US |
53 | 2 |
Postoperative ileus, Device occlusion, Chest pain, Influenza, Abdominal adhesions, |
||||
DIROXIMEL FUMARATE, DIMETHYL FUMARATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FINASTERIDE, GABAPENTIN, |
||||
| 342 | 26840626 |
US |
72 | 2 |
Pneumonia, Injection site pain, Injection site swelling, Injection site mass, Rash macular, Dizziness, Dyspnoea, Product dose omission issue, Influenza, Sinusitis, COVID-19, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 343 | 26840910 |
US |
1 | |
Influenza, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 344 | 26841521 |
US |
57 | |
Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 345 | 26841905 |
US |
2 | |
Influenza, |
||||
| 346 | 26842368 |
US |
1 | |
Haematemesis, Influenza, Epistaxis, Gastrointestinal disorder, Diarrhoea, Reticulocyte count increased, |
||||
OSELTAMIVIR PHOSPHATE, |
||||
| 347 | 26842385 |
CA |
53 | |
Thyroid operation, Pyrexia, Influenza, Product dose omission issue, Product prescribing issue, Inappropriate schedule of product administration, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 348 | 26842599 |
EU |
46 | 2 |
Condition aggravated, Pneumocystis jirovecii infection, Retroperitoneal cancer, Campylobacter bacteraemia, Immunodeficiency, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, COVID-19, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 349 | 26843048 |
US |
62 | 2 |
Withdrawal syndrome, Respiratory rate decreased, Hypertension, Depressed level of consciousness, Pyrexia, Influenza, Headache, Vomiting, Dysarthria, Miosis, Drug ineffective, Drug delivery system issue, Product substitution issue, |
||||
BUPRENORPHINE, BUPRENORPHINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 350 | 26843234 |
US |
72 | 2 |
Influenza, |
||||
ABATACEPT, |
||||
| 351 | 26844268 |
BR |
8 | 1 |
Influenza, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 352 | 26844526 |
43 | ||
Sepsis, Colitis, Gastrointestinal haemorrhage, Cerebrovascular accident, Hemiparesis, Cytomegalovirus colitis, Pneumonia pseudomonal, Liver injury, Influenza, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, SIROLIMUS, MICAFUNGIN, MICAFUNGIN SODIUM, BUDESONIDE, FOSCARNET SODIUM, |
||||
| 353 | 26848767 |
36 | 2 | |
Atrioventricular block first degree, Influenza, |
||||
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE, RITONAVIR, ERGOCALCIFEROL, ETONOGESTREL, |
||||
| 354 | 26834568 |
US |
68 | 1 |
Influenza, Illness, |
||||
LEBRIKIZUMAB-LBKZ, LEBRIKIZUMAB-LBKZ, |
||||
| 355 | 26834666 |
US |
81 | 2 |
Influenza, |
||||
POMALIDOMIDE, POMALIDOMIDE, |
||||
| 356 | 26834750 |
US |
1 | |
Pneumonia, Influenza, |
||||
DUPILUMAB, |
||||
| 357 | 26835022 |
US |
||
Headache, Fibromyalgia, Influenza, Dizziness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 358 | 26835218 |
CO |
45 | 2 |
Asthmatic crisis, Respiratory tract congestion, Dyspnoea, Influenza, Cough, Nasal congestion, Pain in extremity, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 359 | 26835338 |
BR |
6 | 1 |
Influenza, Inappropriate schedule of product administration, |
||||
RAVULIZUMAB, RAVULIZUMAB, |
||||
| 360 | 26835868 |
CA |
65 | 1 |
Crohn^s disease, COVID-19, Influenza, Incorrect dose administered, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 361 | 26836082 |
US |
36 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, DUPILUMAB, BENRALIZUMAB, |
||||
| 362 | 26836085 |
EU |
63 | 1 |
Malaise, Pyrexia, Influenza, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, |
||||
| 363 | 26836593 |
US |
51 | 2 |
Angina pectoris, Injection site haemorrhage, Blood cholesterol increased, Injection site indentation, Drug dose omission by device, Influenza, Product storage issue, Device difficult to use, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 364 | 26836962 |
EU |
51 | |
Klebsiella bacteraemia, Influenza, |
||||
(DAUNORUBICIN AND CYTARABINE) LIPOSOME, |
||||
| 365 | 26837254 |
US |
2 | 1 |
Influenza, Pyrexia, Weight decreased, Dermatitis atopic, Therapeutic response shortened, Therapeutic response decreased, |
||||
DUPILUMAB, EPINEPHRINE, |
||||
| 366 | 26837621 |
BR |
36 | 2 |
Acute myocardial infarction, Influenza, Coronary artery dissection, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 367 | 26837925 |
US |
2 | |
Fatigue, COVID-19, Chest discomfort, Increased bronchial secretion, Sputum discoloured, Increased viscosity of bronchial secretion, Influenza, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 368 | 26838205 |
US |
2 | |
Nasopharyngitis, Influenza, |
||||
TIRZEPATIDE, |
||||
| 369 | 26838427 |
CA |
63 | 1 |
Localised infection, Hip surgery, Intestinal perforation, Blindness transient, Ingrowing nail, Idiopathic pulmonary fibrosis, Fatigue, Blood cholesterol increased, Nephrolithiasis, Herpes zoster, Product odour abnormal, Hip arthroplasty, Weight decreased, Influenza, Mobility decreased, Hypovitaminosis, Irritability, Fall, Diverticulitis, Dyspnoea, Loss of consciousness, Irritable bowel syndrome, Pain, Weight decreased, Memory impairment, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 370 | 26838702 |
|||
Influenza, Rash, |
||||
LENIOLISIB, |
||||
| 371 | 26838730 |
US |
2 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 372 | 26838748 |
US |
46 | 2 |
Influenza, Pyrexia, Upper respiratory tract congestion, |
||||
DUPILUMAB, INFLIXIMAB, |
||||
| 373 | 26839112 |
US |
68 | 2 |
Influenza, Chest discomfort, Cough, Pyrexia, Headache, |
||||
DUPILUMAB, |
||||
| 374 | 26846343 |
1 | ||
Influenza, |
||||
CABOTEGRAVIR, |
||||
| 375 | 26829838 |
EU |
63 | 1 |
Dystonia, Muscle rigidity, Mobility decreased, Gait disturbance, Cognitive disorder, Device issue, Device leakage, On and off phenomenon, Bradykinesia, Freezing phenomenon, Muscle spasms, Middle insomnia, Asthenia, Fatigue, Influenza, Headache, Psychotic disorder, Drug dependence, Malaise, General physical health deterioration, Musculoskeletal stiffness, Loss of personal independence in daily activities, Walking aid user, Therapeutic product effect incomplete, Dyskinesia, Cognitive disorder, Pain, |
||||
CLOZAPINE, RIVASTIGMINE, |
||||
| 376 | 26830621 |
CO |
85 | 1 |
Infarction, Influenza, |
||||
| 377 | 26832574 |
MX |
37 | 2 |
Bradycardia, Immunodeficiency, Heart rate decreased, Influenza, Heart rate increased, Sinus rhythm, Vessel puncture site haematoma, Vascular access site bruising, Phlebitis, Poor venous access, Vessel puncture site bruise, Malaise, Sneezing, Lacrimation increased, Hypersomnia, Illness, Myalgia, Chills, Pyrexia, Lymphopenia, Lymphocyte count decreased, Product storage issue, Rash, Heart rate increased, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, DOPAMINE HYDROCHLORIDE, DOPAMINE, |
||||
| 378 | 26832878 |
PR |
2 | |
Influenza, Pyrexia, Facial discomfort, Head discomfort, Ear discomfort, Inflammation, Gastroenteritis viral, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 379 | 26833026 |
GB |
57 | 1 |
Multiple sclerosis, Fatigue, Balance disorder, Brain fog, Tremor, Lethargy, Chills, Fatigue, Headache, Pyrexia, Influenza, Chills, Weight increased, Therapeutic response shortened, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 380 | 26833347 |
CA |
75 | 2 |
Compression fracture, Taste disorder, Aphonia, Dysgeusia, Influenza, Dyspnoea exertional, Back pain, Disease progression, Abdominal discomfort, Diarrhoea, Oropharyngeal pain, Productive cough, Sneezing, Feeling abnormal, Nasopharyngitis, Malaise, Vomiting, Spinal fracture, |
||||
NINTEDANIB, |
||||
| 381 | 26833503 |
34 | 2 | |
Sinus tachycardia, Sinus bradycardia, Osteomyelitis chronic, Influenza, |
||||
BUPRENORPHINE, |
||||
| 382 | 26833823 |
EU |
61 | 2 |
Influenza, Headache, Malaise, Rash, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, |
||||
| 383 | 26833977 |
GB |
||
Cytomegalovirus viraemia, Viraemia, Human herpesvirus 6 viraemia, Epstein-Barr virus infection, Leukaemia, Influenza, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, TREOSULFAN, FLUDARABINE PHOSPHATE, THIOTEPA, |
||||
| 384 | 26834063 |
US |
13 | 1 |
Nasopharyngitis, Influenza, |
||||
ELOSULFASE ALFA, |
||||
| 385 | 26834208 |
CA |
2 | |
Arrhythmia, Influenza, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, PREDNISONE, PREDNISONE, ZOLPIDEM TARTRATE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SITAGLIPTIN, GLYBURIDE, CITALOPRAM, RISEDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DAPSONE GEL, 5%, DAPSONE, DASPONE, |
||||
| 386 | 26825180 |
BR |
23 | 1 |
Ankylosing spondylitis, Influenza, Off label use, Abscess, Furuncle, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 387 | 26825718 |
EU |
28 | |
Angioedema, Heart rate increased, Palpitations, Pruritus, Influenza, Pyrexia, Suspected off label use, |
||||
OMALIZUMAB-IGEC, |
||||
| 388 | 26825869 |
US |
5 | 2 |
Pneumonia, Pyrexia, Dehydration, Influenza, Defaecation disorder, Skin fissures, Eyelid bleeding, Skin exfoliation, Pruritus, Eyelid skin dryness, |
||||
DUPILUMAB, BARICITINIB, |
||||
| 389 | 26826279 |
CA |
41 | 2 |
Influenza, Lower respiratory tract infection, |
||||
ALBUTEROL SULFATE, |
||||
| 390 | 26826452 |
CA |
19 | 2 |
Colitis ulcerative, Influenza, |
||||
INFLIXIMAB, PANTOPRAZOLE, AZATHIOPRINE, ATOMOXETINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, MIRTAZAPINE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 391 | 26826894 |
US |
70 | 2 |
Diarrhoea, Pneumonia, Influenza, Fall, Back pain, Hypertension, Abdominal pain upper, Hepatotoxicity, Flank pain, |
||||
LENVATINIB, LENVATINIB, PROCHLORPERAZINE MALEATE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DOCUSATE SODIUM, RIVAROXABAN, AMLODIPINE, INSULIN GLARGINE, AZELASTINE, MEGESTROL ACETATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CITALOPRAM, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE, ERGOCALCIFEROL, LOVASTATIN, NAPROXEN, NAPROXEN SODIUM, GLIMEPIRIDE, SITAGLIPTIN, UMECLIDINIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DAPAGLIFLOZIN, GABAPENTIN, LORAZEPAM, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 392 | 26827060 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, Pyrexia, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ONDANSETRON HYDROCHLORIDE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, BISOPROLOL FUMARATE, ERGOCALCIFEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MORPHINE, MORPHINE, PROCHLORPERAZINE, IRBESARTAN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, IRBESARTAN, METHOTREXATE, METHOTREXATE SODIUM, LISINOPRIL, LEVOTHYROXINE SODIUM, PREDNISONE, RAMIPRIL, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LISINOPRIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, PREDNISOLONE SODIUM PHOSPHATE, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, PREGABALIN, METHYLPREDNISOLONE ACETATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
| 393 | 26827152 |
CA |
1 | |
Influenza, |
||||
PREDNISONE, ABIRATERONE ACETATE, |
||||
| 394 | 26827504 |
CA |
17 | 2 |
Influenza, Treatment delayed, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 395 | 26828178 |
1 | ||
Pneumonia, Influenza, Staphylococcal infection, Asthenia, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 396 | 26829288 |
US |
78 | 2 |
Pyrexia, Influenza, Nasopharyngitis, Viral infection, Cellulitis, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 397 | 26829298 |
44 | 2 | |
Ototoxicity, Hypoacusis, Nausea, Dizziness, Influenza, Dry skin, Skin discolouration, Vision blurred, Dry eye, Toxicity to various agents, Hepatic pain, Urine abnormality, Abdominal pain upper, Constipation, Ear congestion, Tongue discomfort, Tongue haemorrhage, Coating in mouth, Aversion, Mucosal inflammation, Ageusia, Inflammation, Peripheral venous disease, Vein disorder, Fatigue, Hepatic steatosis, Anal inflammation, Proctalgia, Anal haemorrhage, Gastrointestinal pain, Dysphagia, Headache, Blood glucose increased, Exercise tolerance decreased, Generalised oedema, Ear discomfort, Skin papilloma, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 398 | 26829522 |
US |
34 | 2 |
Osteomyelitis, Sinus tachycardia, Sinus bradycardia, Influenza, |
||||
BUPRENORPHINE, OSELTAMIVIR PHOSPHATE, |
||||
| 399 | 26819448 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, Pyrexia, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, ERGOCALCIFEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MORPHINE, MORPHINE, ONDANSETRON HYDROCHLORIDE, PROCHLORPERAZINE, IRBESARTAN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, IRBESARTAN, METHOTREXATE, METHOTREXATE SODIUM, LISINOPRIL, LEVOTHYROXINE SODIUM, PREDNISONE, RAMIPRIL, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LISINOPRIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, PREDNISOLONE SODIUM PHOSPHATE, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, PREGABALIN, METHYLPREDNISOLONE ACETATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
| 400 | 26819995 |
CA |
65 | |
Adjustment disorder, Affect lability, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Dysarthria, Eating disorder, Fall, Gastrointestinal disorder, Hemiparesis, Hemiplegia, Motor dysfunction, Muscle spasticity, Neurologic neglect syndrome, Palpitations, Personality disorder, Pneumonia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, Angina pectoris, Anxiety, Cough, Cystitis, Dysphagia, Fatigue, Gangrene, Headache, Influenza, Influenza like illness, Malaise, Muscular weakness, Nasopharyngitis, Nausea, Pain, Pyrexia, Psoriasis, Sinusitis, Product use issue, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM CARBONATE, ANTACID, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, DIMENHYDRINATE, DIMENHYDRINATE, SITAGLIPTIN, ATORVASTATIN CALCIUM, PREGABALIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, PREDNISONE, PROCHLORPERAZINE, BISOPROLOL FUMARATE, IRBESARTAN, IRBESARTAN, IRBESARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN CALCIUM, USTEKINUMAB, LEVOTHYROXINE SODIUM, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30